Nevro Corp (NVRO)
5.29
+0.09
(+1.73%)
USD |
NYSE |
Sep 27, 16:00
5.285
0.00 (0.00%)
After-Hours: 20:00
Nevro SG&A Expense (TTM): 326.85M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 326.85M |
March 31, 2024 | 336.84M |
December 31, 2023 | 334.70M |
September 30, 2023 | 334.76M |
June 30, 2023 | 331.79M |
March 31, 2023 | 329.00M |
December 31, 2022 | 322.14M |
September 30, 2022 | 324.13M |
June 30, 2022 | 325.46M |
March 31, 2022 | 315.36M |
December 31, 2021 | 309.31M |
September 30, 2021 | 293.75M |
June 30, 2021 | 282.74M |
March 31, 2021 | 269.02M |
December 31, 2020 | 267.15M |
September 30, 2020 | 276.09M |
June 30, 2020 | 280.48M |
March 31, 2020 | 295.89M |
December 31, 2019 | 305.81M |
September 30, 2019 | 301.08M |
June 30, 2019 | 292.18M |
Date | Value |
---|---|
March 31, 2019 | 281.32M |
December 31, 2018 | 266.61M |
September 30, 2018 | 257.07M |
June 30, 2018 | 246.04M |
March 31, 2018 | 235.61M |
December 31, 2017 | 219.71M |
September 30, 2017 | 201.80M |
June 30, 2017 | 184.46M |
March 31, 2017 | 164.50M |
December 31, 2016 | 142.42M |
September 30, 2016 | 126.21M |
June 30, 2016 | 112.47M |
March 31, 2016 | 97.98M |
December 31, 2015 | 82.47M |
September 30, 2015 | 63.91M |
June 30, 2015 | 49.20M |
March 31, 2015 | 36.70M |
December 31, 2014 | 29.78M |
September 30, 2014 | 26.26M |
June 30, 2014 | 23.57M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
267.15M
Minimum
Dec 2020
336.84M
Maximum
Mar 2024
308.12M
Average
312.34M
Median
SG&A Expense (TTM) Benchmarks
Myomo Inc | 20.12M |
Inspire Medical Systems Inc | 495.06M |
Axonics Inc | 264.58M |
Inari Medical Inc | 406.98M |
Electromed Inc | 34.49M |